Company
Evernow
No comparable monthly price verified. Dated notes below explain advertised amounts, billing periods and remaining uncertainty.
Published by Treatment Registry · Latest research
- 3 programs
- 2 identified molecules
- 5 readings
Read from evernow.com; latest program check October 2026. Individual programs and sources may have earlier verification dates.
Go to Evernow
We earn nothing from this link. It opens Evernow's website without a paid referral.
Terms
- Pharmacy
Not disclosed
Across recorded programs · Evidence: October 2026
- Membership
Not disclosed
Across recorded programs · Evidence: October 2026
- Consultation fee
Not disclosed
Across recorded programs · Evidence: October 2026
- States
Not disclosed
Across recorded programs · Evidence: October 2026
Programs
More columns to the right? Scroll across the table to see all details.
| Entry | Program | Form | Recorded price with its payment basis | Link |
|---|---|---|---|---|
| EntryTR-0987 | ProgramBrand semaglutide | FormInjection, pen | Recorded priceNo comparable monthly price | Record |
| EntryTR-0988 | ProgramBrand tirzepatide | FormInjection, pen | Recorded priceNo comparable monthly price | Record |
| EntryTR-1018 | ProgramBrand semaglutide | FormOral tablet | Recorded priceNo comparable monthly price | Record |
Notes
Pricing details, service terms and questions to confirm before enrolling.
October 2026
- 1. Evernow’s general care-options page advertises membership starting at $35 per month and membership-free visits with a menopause provider. Its weight-loss enrollment page asks patients to select a membership plan. Whether the per-visit option applies to GLP-1 care, and the required GLP-1 care fee, are not established by those pages. Medication costs are separate. https://www.evernow.com/how-it-works https://www.evernow.com/care/weight-loss
- 2. Evernow also mentions compounded GLP-1 alternatives in its shortage FAQ without identifying a specific molecule, preparation or price. The public description does not establish an additional named compounded program. https://www.evernow.com/prescription/weight-loss/ozempic
Show 6 more notesHide 6 more notes
- 3. Evernow explicitly lists Rybelsus among available prescription options, subject to clinical assessment. Rybelsus is branded semaglutide in oral tablets; its medicine price is separate from care and was not established in the reviewed catalog. https://www.evernow.com/care/weight-loss https://www.novo-pi.com/rybelsus.pdf
- 4. General care-options and video visit information: https://www.evernow.com/how-it-works . General pharmaceutical-return terms: https://www.evernow.com/legal/terms .
October 2026
- 5. Ozempic and Wegovy are listed as prescribing options. The ozempic page describes a prefilled pen; coverage and final product selection depend on clinical assessment. https://www.evernow.com/prescription/weight-loss/ozempic
- 6. Medication is priced separately from care and may be sent to a local pharmacy or delivered. Membership is optional alongside per-visit video care. https://www.evernow.com/how-it-works
- 7. Returns policy: https://www.evernow.com/legal/terms
- 8. Zepbound and Mounjaro are listed as prescribing options. The zepbound page describes a prefilled pen; coverage and final product selection depend on clinical assessment. https://www.evernow.com/prescription/weight-loss/zepbound
Understand the terms
- Cancellation and refunds
Ending future billing and refunding an existing order are separate questions.
Before you act
Cite this
Treatment Registry. (2026). Evernow: recorded programs and prices. Last verified October 2026. Retrieved [your access date], from https://treatmentregistry.com/providers/evernow